William Blair Upgrades ResMed (RMD) to Outperform
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $188.45 -0.1%
Rating Summary:
13 Buy, 10 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
13 Buy, 10 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
William Blair upgraded ResMed (NYSE: RMD) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $47.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- This digital health stock is ready to re-rate higher: Goldman
- Barclays Upgrades Visteon (VC) to Overweight
- Morgan Stanley Downgrades ResMed (RMD) to Equalweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
